Total Funding
88
71
Total FundingSeries B raised
Growth Score 88 in past quarter
-5 pts
Heat Score 71 in past quarter
40 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
11675
Qihan Biotech is a gene-editing organ transplantation technology developer.
- Yingyong Xu: Chief Medical Officer
Luhan Yang: Founder and CEOPast Role: EGenesis, CSO & co-founder
About the Company
Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation,
and to solve the serious shortage of organ transplant donors in China and the world.